主动脉内球囊反搏在急性心肌梗死中应用效果及发生血栓管理的研究进展

doi:10.3969/j.issn.1006-5725.2024.14.022

Abstract

Abstract:

Acute myocardial infarction has the characteristics of rapid progression， dangerous condition， unstable hemodynamics， and is prone to thrombosis， resulting in a high clinical mortality rate. Intra-aortic balloon counterpulsation （IABP） has the function of increasing intra-aortic diastolic pressure， reducing left ventricular afterload， and enhancing coronary artery blood supply. It is a common auxiliary and transitional treatment method for coronary intervention， which can significantly improve the safety and clinical efficacy of coronary intervention. Therefore， it is widely used in high-risk and complex coronary heart disease， mainly acute myocardial infarction. This article reviews the research progress on the application effect and thrombosis management of IABP in acute myocardial infarction in recent years.

Key words: acute myocardial infarction, intra-aortic balloon counterpulsation, thrombosis, research progress

CLC Number:

R542.22

Yuxuan ZHOU,Jian YANG,Jing ZHANG,Jun. YANG. Research progress on the application effect of IABP in acute myocardial infarction and the management of thrombosis[J]. The Journal of Practical Medicine, 2024, 40(14): 2031-2034.

References 33

1	DAMLUJI A A， VAN DIEPEN S， KATZ J N， et al Mechanical Complications of Acute Myocardial Infarction ： A Scientific Statement From the American Heart Association［J］. Circulation， 2021，144（2）：e16-e35. doi:10.1161/cir.0000000000000985 doi: 10.1161/cir.0000000000000985
2	SAITO Y， OYAMA K， TSUJITA K， et al. Treatment strategies of acute myocardial infarction： updates on revascularization， pharmacological therapy， and beyond［J］. J Cardiol，2023，81（2）：168-178. doi:10.1016/j.jjcc.2022.07.003 doi: 10.1016/j.jjcc.2022.07.003
3	MEYERS H P， BRACEY A， LEE D， et al. Comparison of the ST-Elevation Myocardial Infarction （STEMI） vs. NSTEMI and Occlusion MI （OMI） vs. NOMI Paradigms of Acute MI［J］. J Emerg Med，2021，60（3）：273-284. doi:10.1016/j.jemermed.2020.10.026 doi: 10.1016/j.jemermed.2020.10.026
4	孙天保，贺莹，高鹏燕，等. IABP联合急诊PCI术对急性心肌梗死后心源性休克患者平均动脉压、乳酸水平的影响［J］. 川北医学院学报， 2020，35（3）：417-419. doi:10.3969/j.issn.1005-3697.2020.03.015 doi: 10.3969/j.issn.1005-3697.2020.03.015
5	郭超，杨昊翰，王心宇，等. 主动脉内球囊反搏置入时机对急性心肌梗死合并心原性休克患者预后的影响［J］. 中国循环杂志， 2022，37（8）：782-788. doi:10.3969/j.issn.1000-3614.2022.08.004 doi: 10.3969/j.issn.1000-3614.2022.08.004
6	IMAMURA T， JURICEK C， NGUYEN A， et al. Predictors of Hemodynamic Improvement and Stabilization Following Intraaortic Balloon Pump Implantation in Patients With Advanced Heart Failure［J］. J Invasive Cardiol， 2018，30（2）： 56-61.
7	孔祥勇，陈鸿武，余晓凡，等. 主动脉内球囊反搏对暴发性心肌炎引起难治性心源性休克患者的临床疗效［J］. 中国临床保健杂志， 2019，22（5）：584-587. doi:10.3969/J.issn.1672-6790.2019.05.003 doi: 10.3969/J.issn.1672-6790.2019.05.003
8	马贵洲，徐荣和，周琳洁，等. 急性前壁心肌梗死患者急诊经皮冠脉介入术后主动脉内球囊反搏与重组人脑利钠肽对心功能的保护作用［J］. 实用医学杂志，2022，38（21）：2720-2726. doi:10.3969/j.issn.1006-5725.2022.21.016 doi: 10.3969/j.issn.1006-5725.2022.21.016
9	陈慧敏，赵冬，石春来. IABP对老年心血管危重症病人心功能及血流动力学的影响［J］. 中西医结合心脑血管病杂志，2019，17（22）：3634-3636. doi:10.12102/j.issn.1672-1349.2019.22.050 doi: 10.12102/j.issn.1672-1349.2019.22.050
10	KARAMI M， ERIKSEN E， OUWENEEL D M， et al. Long-term 5-year outcome of the randomized IMPRESS in severe shock trial： percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction［J］. Eur Heart J Acute Cardiovasc Care，2021，10（9）：1009-1015. doi:10.1093/ehjacc/zuab020.210 doi: 10.1093/ehjacc/zuab020.210
11	DHRUVA S S， ROSS J S， MORTAZAVI B J， et al. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock［J］. JAMA，2020，323（8）：734-745. doi:10.1001/jama.2020.0254 doi: 10.1001/jama.2020.0254
12	罗晓亮，张峻，袁建松，等. 主动脉内球囊反搏在急性心肌梗死合并室间隔穿孔患者中的临床应用及并发症情况分析［J］. 中国分子心脏病学杂志，2019，19（6）：3131-3134.
13	李琴，檀鑫，姜文溪，等. 急性心肌梗死患者经皮冠状动脉介入治疗后远期主要不良心血管事件预测模型的构建［J］. 中国全科医学，2022，25（24）：2965-2974. doi:10.12114/j.issn.1007-9572.2022.0237 doi: 10.12114/j.issn.1007-9572.2022.0237
14	陈兰涛，吴田田，陈敬，等. 主动脉内球囊反搏联合左西孟旦治疗急性心肌梗死心源性休克患者的临床疗效观察［J］. 中国中西医结合急救杂志， 2022，29（5）：529-534. doi:10.3969/j.issn.1008-9691.2022.05.004 doi: 10.3969/j.issn.1008-9691.2022.05.004
15	CHEN Z， GAO Y， LIN Y. Perspectives and Considerations of IABP in the Era of ECMO for Cardiogenic Shock［J］. Adv Ther， 2023，40（10）：4151-4165. doi:10.1007/s12325-023-02598-8 doi: 10.1007/s12325-023-02598-8
16	韩宗茂，高洁，高传玉，等. 早期血运重建及体外膜肺氧合支持治疗急性心肌梗死合并心原性休克的疗效观察及影响因素分析［J］. 中国循环杂志， 2021，36（5）：433-438. doi:10.3969/j.issn.1000-3614.2021.05.004 doi: 10.3969/j.issn.1000-3614.2021.05.004
17	邱承杰，陈玉善，解金红，等. 体外膜肺氧合联合主动脉内球囊反搏对急性心肌梗死合并心原性休克患者直接经皮冠状动脉介入治疗临床预后的影响［J］. 中国心血管杂志， 2021，26（3）：257-261. doi:10.3969/j.issn.1007-5410.2021.03.011 doi: 10.3969/j.issn.1007-5410.2021.03.011
18	张慧霞，张超红. 主动脉球囊反搏联合急诊PCI对急性心肌梗死合并心源性休克病人术后血清cTnI、 NSE、 PCT水平及生存质量的影响［J］. 中西医结合心脑血管病杂志，2019，17（5）：748-751. doi:10.12102/j.issn.1672-1349.2019.05.028 doi: 10.12102/j.issn.1672-1349.2019.05.028
19	赵国敏，边伟帅，陈炜. 主动脉球囊反搏术对脓毒症休克合并低心排血量患者心脏指数、动脉血乳酸水平及短期预后的影响［J］. 广西医学，2023，45（12）：1414-1417.
20	蔡庆慧，郭长英，陈红卫，等. 主动脉内球囊反搏不同应用时机的疗效研究［J］. 心肺血管病杂志，2021，40（6）：592-596. doi:10.3969/j.issn.1007-5062.2021.06.015 doi: 10.3969/j.issn.1007-5062.2021.06.015
21	史坚，张静波，邢震宇，等. 非体外循环冠状动脉旁路移植术围术期应用IABP病人血糖变异水平与并发症发生风险的关系［J］. 中西医结合心脑血管病杂志，2021，19（17）：2986-2989. doi:10.12102/j.issn.1672-1349.2021.17.024 doi: 10.12102/j.issn.1672-1349.2021.17.024
22	杜林翔，王娜. IABP辅助PCI治疗老年ACS合并心力衰竭患者的疗效分析［J］. 临床心血管病杂志，2020，36（4）：352-354.
23	李丹，胡昊，吴佳纬，等. IABP辅助经皮冠状动脉介入治疗高危冠心病患者的危险因素［J］. 中国老年学杂志，2021，41（6）：1121-1124. doi:10.3969/j.issn.1005-9202.2021.06.001 doi: 10.3969/j.issn.1005-9202.2021.06.001
24	桑梓楠，张凤伟，高宗炜. 静脉-静脉转流的体外膜肺氧合模式联合主动脉内球囊反搏术抢救多支冠状动脉完全闭塞合并急性重症肺水肿一例报道［J］. 实用心脑肺血管病杂志， 2020，28（9）：134-137. doi:10.3969/j.issn.1008-5971.2020.09.027 doi: 10.3969/j.issn.1008-5971.2020.09.027
25	崔晓娜，冯瑞霞，韩雨澎，等. 静脉-动脉体外膜肺氧合和主动脉内球囊反搏联合辅助顺序对急性心肌梗死合并心源性休克患者的临床效果比较研究［J］. 中国全科医学， 2023，26（35）：4439-4445. doi:10.12114/j.issn.1007-9572.2023.0248 doi: 10.12114/j.issn.1007-9572.2023.0248
26	张威，程云涛，谭咏梅，等. Impella与IABP治疗急性心肌梗死致心源性休克的临床观察［J］. 中华生物医学工程杂志，2019，25（3）：356-359. doi:10. 3760/cma. j. issn. 1674?1927. 2019. 03. 018 doi: 10. 3760/cma. j. issn. 1674?1927. 2019. 03. 018
27	魏金刚，王素星，刘振中，等. 红花黄色素预防重症破伤风下肢静脉血栓形成的效果［J］. 实用医学杂志，2019，35（22）：3527-3530. doi:10.3969/j.issn.1006-5725.2019.22.021 doi: 10.3969/j.issn.1006-5725.2019.22.021
28	王鹏，赵玉洁，任杰. 利伐沙班、华法林对急性心肌梗死合并左心室血栓患者的疗效观察［J］. 血栓与止血学，2022，28（3）：774-775. doi:10.3969/j.issn.1009-6213.2022.03.190 doi: 10.3969/j.issn.1009-6213.2022.03.190
29	SHAH A， ONWUMBIKO B， ENCARNACION C O， et al. Implantation of Left Ventricular Assist Device After Descending Aortic Stent Graft for Mural Thrombus［J］. Heart Surg Forum，2020，23（1）：E007-E009. doi:10.1532/hsf.2675 doi: 10.1532/hsf.2675
30	NDAO S C T， AMARA W BEN， ZABALAWI A， et al. Dissection coronaire spontanée dans le SCA ST+ chez un homme jeune ： échec de fibrinolyse ［Spontaneous coronary artery dissection in young male patient with STEMI： Unsuccessful fibrinolysis］［J］. Ann Cardiol Angeiol （Paris），2021，70（1）：47-50. doi:10.1016/j.ancard.2020.03.011 doi: 10.1016/j.ancard.2020.03.011
31	WOLLER S C， STEVENA S M， KAPLAN D， et al. Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome： a randomized trial［J］. Blood Adv， 2022，6（6）：1661-1670. doi:10.1182/bloodadvances.2021005808 doi: 10.1182/bloodadvances.2021005808
32	DE VRIESE A S， CALUWE R， VAN DER MEERSCH H， et al. Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation： A Multicenter Randomized Controlled Trial［J］. J Am Soc Nephrol，2021，32（6）：1474-1483. doi:10.1681/asn.2020111566 doi: 10.1681/asn.2020111566
33	胡彦，马仰，张剑平. 下腔静脉滤器置入联合溶栓与利伐沙班治疗下肢深静脉血栓临床效果［J］. 皖南医学院学报，2023，42（4）：351-354. doi:10.3969/j.issn.1002-0217.2023.04.012 doi: 10.3969/j.issn.1002-0217.2023.04.012

[1]	Jianlong SHENG,Ni′na. LIU. The advanced progress on the relationship between hyperuricemia and acute myocardial infarction [J]. The Journal of Practical Medicine, 2024, 40(5): 727-730.
[2]	Shan GAO,Kun JI,Li ZHAO,Yujia XING,Yandong XIE,Xiqiang CAI. Research progress on esophageal squamous intraepithelial neoplasia [J]. The Journal of Practical Medicine, 2024, 40(3): 432-438.
[3]	Xian WEN,Xianfeng ZENG,Ruiya SU. Efficacy of ivabradine combined with levosimendan in patients with acute myocardial infarction complicated with heart failure [J]. The Journal of Practical Medicine, 2024, 40(2): 242-247.
[4]	Shan′gao HUANG,Yueling WU,Ying. ZHANG. Aiming for the future： The latest advances in targeted therapy for ovarian cancer [J]. The Journal of Practical Medicine, 2024, 40(14): 1901-1907.
[5]	Yapeng LIANG,Chaopu ZHANG,Hao ZHANG,Zhongqun. WANG. The relationship between the expression of serum ANGPTL8 and KLF2 and the degree of coronary artery disease and the occurrence of major adverse cardiac events in patients with acute myocardial infarction [J]. The Journal of Practical Medicine, 2024, 40(13): 1827-1832.
[6]	Youming ZHANG,Junhui GONG,Hongtao ZHU. Relationship between serum CTRP12 level and in⁃stent restenosis in patients with acute myocardial infarction after percutaneous coronary intervention [J]. The Journal of Practical Medicine, 2024, 40(12): 1671-1676.
[7]	Haixia YUAN,Xinmin HAN,Tianyi CHEN,Yuchen. SONG. Progress on structural abnormalities in the cerebral cortex in children with attention deficit/hyperactivity disorder [J]. The Journal of Practical Medicine, 2024, 40(10): 1455-1459.
[8]	Yadan CHE,Lixia. LI. Reaserch progress on small molecule anti⁃angiogenic drugs for advanced breast cancer [J]. The Journal of Practical Medicine, 2023, 39(22): 2866-2871.
[9]	Jianghao PAN,Jianming SUN,Jiaming SONG,Guangyin FU,Yong LEI,Xiaojie. ZHANG. Evaluation value of monitoring changes of ultrasonic elastic imaging parameters before and after CDT combined with ART in patients with acute deep venous thrombosis of lower extremities [J]. The Journal of Practical Medicine, 2023, 39(18): 2362-2367.
[10]	bater Hurile,Hongli WU,Xueting LIU,Zhipeng LI,Zhipeng YANG,Hongjun WANG,Qi XIN,Hongwei. CHEN. Predictors of early left ventricular thrombus in elderly patients with anterior acute ST segment elevation myocardial infarction receiving emergency percutaneous coronary intervention [J]. The Journal of Practical Medicine, 2023, 39(17): 2230-2235.
[11]	YANG Shaowang.. Construction of a risk model of contrast⁃ induced nephropathy after percutaneous coronary intervention for acute myocardial infarction [J]. The Journal of Practical Medicine, 2023, 39(15): 1925-1931.
[12]	WANG Zhenzhen, SUN Zirui, LIU Yuhao. . Different surgical approaches to postinfarction ventricular septal rupture after acute myocardial infarction： surgical repair vs. transcatheter interventional closure [J]. The Journal of Practical Medicine, 2023, 39(14): 1774-1778.
[13]	WANG Fabin, SUN Menghan, ZHAO Qiang, MA Teng, LIU Fengjun, YANG Dacheng. . Efficacy and safety of early application of Dapagliflozin in patients undergoing emergency PCI after acute myocardial infarction [J]. The Journal of Practical Medicine, 2023, 39(13): 1688-1692.
[14]	LIU Hui, HE Caixian, PENG Jiyong, ZHONG Xi, LIAO Kai, YUAN Yawei, ZHENG Ronghui.. Carotid arterial injuries caused by radiotherapy for nasopharyngeal carcinoma：A review [J]. The Journal of Practical Medicine, 2023, 39(10): 1201-1205.
[15]	WAN Jun, XU Feng, WANG Yulin, CHENG Jinglin, LIANG Youfeng.. Relationship of serum Lp（a）and S100A4 expression level with platelet activation in patients with acute myocardial infarction and its influence on major adverse cardiac events [J]. The Journal of Practical Medicine, 2022, 38(8): 929-933.

Research progress on the application effect of IABP in acute myocardial infarction and the management of thrombosis

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 33

Related Articles 15

Recommended Articles

Metrics

Comments